Skip to main content
The BMJ logoLink to The BMJ
. 1989 Jun 3;298(6686):1467–1468. doi: 10.1136/bmj.298.6686.1467

Hormone replacement treatment.

P Belchetz 1
PMCID: PMC1836678  PMID: 2503073

Full text

PDF
1467

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chow R., Harrison J. E., Notarius C. Effect of two randomised exercise programmes on bone mass of healthy postmenopausal women. Br Med J (Clin Res Ed) 1987 Dec 5;295(6611):1441–1444. doi: 10.1136/bmj.295.6611.1441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cooper C., Barker D. J., Wickham C. Physical activity, muscle strength, and calcium intake in fracture of the proximal femur in Britain. BMJ. 1988 Dec 3;297(6661):1443–1446. doi: 10.1136/bmj.297.6661.1443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ettinger B., Genant H. K., Cann C. E. Long-term estrogen replacement therapy prevents bone loss and fractures. Ann Intern Med. 1985 Mar;102(3):319–324. doi: 10.7326/0003-4819-102-3-319. [DOI] [PubMed] [Google Scholar]
  4. Evans G., Jackson R. K. Microdiscectomy for treating lumbar disc protrusion. BMJ. 1988 Jul 2;297(6640):5–5. doi: 10.1136/bmj.297.6640.5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gordon T., Kannel W. B., Hjortland M. C., McNamara P. M. Menopause and coronary heart disease. The Framingham Study. Ann Intern Med. 1978 Aug;89(2):157–161. doi: 10.7326/0003-4819-89-2-157. [DOI] [PubMed] [Google Scholar]
  6. Horsman A., Gallagher J. C., Simpson M., Nordin B. E. Prospective trial of oestrogen and calcium in postmenopausal women. Br Med J. 1977 Sep 24;2(6090):789–792. doi: 10.1136/bmj.2.6090.789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hunt K., Vessey M., McPherson K., Coleman M. Long-term surveillance of mortality and cancer incidence in women receiving hormone replacement therapy. Br J Obstet Gynaecol. 1987 Jul;94(7):620–635. doi: 10.1111/j.1471-0528.1987.tb03166.x. [DOI] [PubMed] [Google Scholar]
  8. Kanis J. A., Passmore R. Calcium supplementation of the diet--I. BMJ. 1989 Jan 21;298(6667):137–140. doi: 10.1136/bmj.298.6667.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kanis J. A., Passmore R. Calcium supplementation of the diet--II. BMJ. 1989 Jan 28;298(6668):205–208. doi: 10.1136/bmj.298.6668.205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Key T. J., Pike M. C. The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol. 1988 Jan;24(1):29–43. doi: 10.1016/0277-5379(88)90173-3. [DOI] [PubMed] [Google Scholar]
  11. Kovacs J. A., Gill V., Swan J. C., Ognibene F., Shelhamer J., Parrillo J. E., Masur H. Prospective evaluation of a monoclonal antibody in diagnosis of Pneumocystis carinii pneumonia. Lancet. 1986 Jul 5;2(8497):1–3. doi: 10.1016/s0140-6736(86)92555-9. [DOI] [PubMed] [Google Scholar]
  12. Lind T., Cameron E. C., Hunter W. M., Leon C., Moran P. F., Oxley A., Gerrard J., Lind U. C. A prospective, controlled trial of six forms of hormone replacement therapy given to postmenopausal women. Br J Obstet Gynaecol. 1979;86 (Suppl 3):1–29. doi: 10.1111/j.1471-0528.1979.tb16232.x. [DOI] [PubMed] [Google Scholar]
  13. Mack T. M., Pike M. C., Henderson B. E., Pfeffer R. I., Gerkins V. R., Arthur M., Brown S. E. Estrogens and endometrial cancer in a retirement community. N Engl J Med. 1976 Jun 3;294(23):1262–1267. doi: 10.1056/NEJM197606032942304. [DOI] [PubMed] [Google Scholar]
  14. Munk-Jensen N., Pors Nielsen S., Obel E. B., Bonne Eriksen P. Reversal of postmenopausal vertebral bone loss by oestrogen and progestogen: a double blind placebo controlled study. Br Med J (Clin Res Ed) 1988 Apr 23;296(6630):1150–1152. doi: 10.1136/bmj.296.6630.1150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Paganini-Hill A., Ross R. K., Gerkins V. R., Henderson B. E., Arthur M., Mack T. M. Menopausal estrogen therapy and hip fractures. Ann Intern Med. 1981 Jul;95(1):28–31. doi: 10.7326/0003-4819-95-1-28. [DOI] [PubMed] [Google Scholar]
  16. Powers M. S., Schenkel L., Darley P. E., Good W. R., Balestra J. C., Place V. A. Pharmacokinetics and pharmacodynamics of transdermal dosage forms of 17 beta-estradiol: comparison with conventional oral estrogens used for hormone replacement. Am J Obstet Gynecol. 1985 Aug 15;152(8):1099–1106. doi: 10.1016/0002-9378(85)90569-1. [DOI] [PubMed] [Google Scholar]
  17. Purdie D. W. Broken bones--a gynaecological problem. Br J Obstet Gynaecol. 1988 Aug;95(8):737–739. doi: 10.1111/j.1471-0528.1988.tb06545.x. [DOI] [PubMed] [Google Scholar]
  18. Riggs B. L., Melton L. J., 3rd Involutional osteoporosis. N Engl J Med. 1986 Jun 26;314(26):1676–1686. doi: 10.1056/NEJM198606263142605. [DOI] [PubMed] [Google Scholar]
  19. Riis B., Thomsen K., Christiansen C. Does calcium supplementation prevent postmenopausal bone loss? A double-blind, controlled clinical study. N Engl J Med. 1987 Jan 22;316(4):173–177. doi: 10.1056/NEJM198701223160401. [DOI] [PubMed] [Google Scholar]
  20. Ross R. K., Paganini-Hill A., Mack T. M., Arthur M., Henderson B. E. Menopausal oestrogen therapy and protection from death from ischaemic heart disease. Lancet. 1981 Apr 18;1(8225):858–860. doi: 10.1016/s0140-6736(81)92138-3. [DOI] [PubMed] [Google Scholar]
  21. Savvas M., Studd J. W., Fogelman I., Dooley M., Montgomery J., Murby B. Skeletal effects of oral oestrogen compared with subcutaneous oestrogen and testosterone in postmenopausal women. BMJ. 1988 Jul 30;297(6644):331–333. doi: 10.1136/bmj.297.6644.331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Schapira D. Physical exercise in the prevention and treatment of osteoporosis: a review. J R Soc Med. 1988 Aug;81(8):461–463. doi: 10.1177/014107688808100815. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Stampfer M. J., Willett W. C., Colditz G. A., Rosner B., Speizer F. E., Hennekens C. H. A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med. 1985 Oct 24;313(17):1044–1049. doi: 10.1056/NEJM198510243131703. [DOI] [PubMed] [Google Scholar]
  24. WUEST J. H., Jr, DRY T. J., EDWARDS J. E. The degree of coronary atherosclerosis in bilaterally oophorectomized women. Circulation. 1953 Jun;7(6):801–809. doi: 10.1161/01.cir.7.6.801. [DOI] [PubMed] [Google Scholar]
  25. Weiss N. S., Ure C. L., Ballard J. H., Williams A. R., Daling J. R. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med. 1980 Nov 20;303(21):1195–1198. doi: 10.1056/NEJM198011203032102. [DOI] [PubMed] [Google Scholar]
  26. Witteman J. C., Grobbee D. E., Kok F. J., Hofman A., Valkenburg H. A. Increased risk of atherosclerosis in women after the menopause. BMJ. 1989 Mar 11;298(6674):642–644. doi: 10.1136/bmj.298.6674.642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Ziel H. K., Finkle W. D. Increased risk of endometrial carcinoma among users of conjugated estrogens. N Engl J Med. 1975 Dec 4;293(23):1167–1170. doi: 10.1056/NEJM197512042932303. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES